Compounds > losartan

losartan and omapatrilat

losartan has been researched along with omapatrilat in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's5 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Abrego, V; Angeles, E; Balboa, MA; Camacho, B; Díaz-Barriga, S; López-Castañares, R; Martínez, L; Romero, A; Torres, LA; Velázquez, AM1
Banerjee, T; Clark, AL; Cleland, JG; Thackray, S; Witte, K1
Giacca, A; Lapointe, N; Leung, N; Lewis, GF; Rouleau, JL; Szeto, L; Uffelman, KD; Wang, CH1
Bäcklund, T; Eriksson, A; Finckenberg, P; Gröholm, T; Laine, M; Mervaala, E; Palojoki, E; Saraste, A; Tikkanen, I1
Abassi, Z; Assady, S; Khankin, E; Kositch, Z; Lewin, M; Nakhoul, F; Ramadan, R; Yaccob, A1

Other Studies

5 other study(ies) available for losartan and omapatrilat

ArticleYear
Synthesis and antihypertensive effects of new methylthiomorpholinphenol derivatives.
    European journal of medicinal chemistry, 2008, Volume: 43, Issue:3

    Topics: Animals; Antihypertensive Agents; Blood Pressure; Dose-Response Relationship, Drug; Drug Design; Heart Rate; Morpholines; Phenols; Rats

2008
Update of ELITE-II, BEST, CHAMP, and IMPRESS clinical trials in heart failure.
    European journal of heart failure, 2000, Volume: 2, Issue:1

    Topics: Adrenergic beta-Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Captopril; Exercise Tolerance; Heart Failure; Humans; Losartan; Pyridines; Randomized Controlled Trials as Topic; Thiazepines

2000
Vasopeptidase inhibitor omapatrilat induces profound insulin sensitization and increases myocardial glucose uptake in Zucker fatty rats: Studies comparing a vasopeptidase inhibitor, angiotensin-converting enzyme inhibitor, and angiotensin II type I recept
    Circulation, 2003, Apr-15, Volume: 107, Issue:14

    Topics: Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Biological Transport; Blood Glucose; Bradykinin; Bradykinin Receptor Antagonists; Drug Synergism; Enzyme Inhibitors; Glucose; Glucose Clamp Technique; Insulin; Insulin Resistance; Losartan; Male; Myocardium; Neprilysin; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Protease Inhibitors; Pyridines; Ramipril; Rats; Rats, Zucker; Receptor, Angiotensin, Type 1; Receptor, Bradykinin B2; Thiazepines

2003
Cardioprotective effects of vasopeptidase inhibition vs. angiotensin type 1-receptor blockade in spontaneously hypertensive rats on a high salt diet.
    Hypertension research : official journal of the Japanese Society of Hypertension, 2004, Volume: 27, Issue:8

    Topics: Aldosterone; Angiotensin II Type 1 Receptor Blockers; Animals; Antihypertensive Agents; Apoptosis; Autoradiography; Body Weight; Cardiotonic Agents; Connective Tissue Growth Factor; Fibrosis; Hydrochlorothiazide; Hypertension; Immediate-Early Proteins; Intercellular Signaling Peptides and Proteins; Losartan; Male; Myocardium; Organ Size; Protease Inhibitors; Pyridines; Rats; Rats, Inbred SHR; Renin; Sodium Chloride, Dietary; Thiazepines

2004
Glomerular abundance of nephrin and podocin in experimental nephrotic syndrome: different effects of antiproteinuric therapies.
    American journal of physiology. Renal physiology, 2005, Volume: 289, Issue:4

    Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Doxorubicin; Enalaprilat; Enzyme Inhibitors; Fluorescent Antibody Technique; Immunohistochemistry; Intracellular Signaling Peptides and Proteins; Kidney Glomerulus; Losartan; Male; Membrane Proteins; Mycophenolic Acid; Nephrotic Syndrome; Protein Synthesis Inhibitors; Proteinuria; Pyridines; Rats; Rats, Sprague-Dawley; Thiazepines

2005